目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 RESEARCH SCOPE
1.3.1 MARKET COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 LIMITATIONS
1.6 MAJOR MARKET STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.2 PRIMARY RESEARCH
2.2.2.1 PRIMARY SOURCES
2.2.2.2 KEY INDUSTRY INSIGHTS
2.2.2.3 BREAKDOWN OF PRIMARIES
2.3 IMPACT OF RECESSION ON DIAGNSOTIC IMAGING MARKET
2.4 MARKET SIZE ESTIMATION
2.4.1 REVENUE-MAPPING BASED MARKET ESTIMATION
2.4.2 PROCEDURE BASED MARKET ESTIMATION
2.4.3 PRIMARY RESEARCH VALIDATION
2.5 DATA TRIANGULATION APPROACH
2.6 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.6.1 RESEARCH ASSUMPTIONS
2.6.2 RESEARCH LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
5.1.1 DRIVERS
5.1.2 RESTRAINTS
5.1.3 KEY GROWTH OPPORTUNITIES
5.1.4 INDUSTRY-SPECIFIC CHALLENGES
5.2 PORTER’S FIVE FORCES ANALYSIS
5.3 REGULATORY LANDSCAPE
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANISATIONS
5.3.2 REGULATORY TRENDS
5.4 REIMBURSEMENT SCENARIO
5.5 ECOSYSTEM COVERAGE
5.6 VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY
5.8.2 AVERAGE SELLING PRICE TREND
5.9 PATENT ANALYSIS
5.10 TRADE ANALYSIS
5.11 TECHNOLOGY ANALYSIS
5.12 KEY CONFERENCES & EVENTS IN 2023-2024
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS
5.14.2 BUYING CRITERIA
5.15 CASE STUDY ANALYSIS
5.16 CUSTOMER UNMET NEEDS AND KEY PAIN POINTS
5.16.1 HOSPITALS
5.16.2 DIAGNOSTIC CENTERS AND IMAGING CLINICS
5.16.3 AMBULATORY CARE CENTERS, AND PHYSICIAN’S CLINICS

6 DIAGNOSTIC IMAGING MARKET, BY PRODUCT (USD MILLION; 2021—2028)*
6.1 CT SCANNERS
6.1.1 CONVENTIONAL CT SCANNERS
6.1.1.1 HIGH-SLICE CT SCANNERS
6.1.1.2 MID-SLICE CT SCANNERS
6.1.1.3 LOW-SLICE CT SCANNERS
6.1.2 CONE-BEAM CT SCANNERS
6.2 ULTRASOUND SYSTEMS
6.2.1 ULTRASOUND SYSTEMS, BY TECHNOLOGY
6.2.1.1 2D ULTRASOUND SYSTEMS
6.2.1.2 3D & 4D ULTRASOUND SYSTEMS
6.2.1.3 DOPPLER ULTRASOUND SYSTEMS
6.2.1.4 CONTRAST-ENHANCED ULTRASOUND SYSTEMS
6.2.2 ULTRASOUND SYSTEMS, BY PORTABILITY
6.2.2.1 TROLLEY/CART BASED ULTRASOUND SYSTEMS
6.2.2.2 COMPACT/HANDHELD ULTRASOUND SYSTEMS
6.2.2.3 POC ULTRASOUND SYSTEMS
6.3 X-RAY IMAGING SYSTEMS
6.3.1 X-RAY IMAGING SYSTEMS, BY TYPE
6.3.1.1 DIGITAL X-RAY IMAGING SYSTEMS
6.3.1.1.1 DIRECT RADIOGRAPHY SYSTEMS
6.3.1.1.2 COMPUTED RADIOGRAPHY SYSTEMS
6.3.1.2 ANALOG X-RAY IMAGING SYSTEMS
6.3.2 X-RAY IMAGING SYSTEMS, BY PORTABILITY
6.3.2.1 STATIONARY X-RAY IMAGING SYSTEMS
6.3.2.2 PORTABLE X-RAY IMAGING SYSTEMS
6.4 MRI SYSTEMS
6.4.1 MRI SYSTEMS, BY ARCHITECTURE
6.4.1.1 CLOSED MRI SYSTEMS
6.4.1.2 OPEN MRI SYSTEMS
6.4.2 MRI SYSTEMS, BY FIELD STRENGTH
6.4.2.1 HIGH AND VERY-HIGH-FIELD MRI SYSTEMS
6.4.2.2 LOW-TO-MID-FIELD MRI SYSTEMS
6.4.2.3 ULTRA-HIGH-FIELD MRI SYSTEMS
6.5 NUCLEAR IMAGING SYSTEMS
6.5.1 STANDALONE SYSTEMS
6.5.1.1 PET SYSTEMS
6.5.1.2 SPECT SYSTEMS
6.5.2 PET/CT SYSTEMS
6.5.2 PET/MRI SYSTEMS
6.6 MAMMOGRAPHY SYSTEMS

7 DIAGNOSTIC IMAGING MARKET, BY APPLICATION (USD MILLION; 2021—2028)*
7.1 X-RAY IMAGING SYSTEMS
7.1.1 GENERAL RADIOGRAPHY
7.1.2 DENTISTRY
7.1.3 FLUOROSCOPY
7.2 MRI SYSTEMS
7.2.1 BRAIN & NEUROLOGICAL MRI
7.2.2 SPINE & MUSCULOSKELETAL MRI
7.2.3 VASCULAR MRI
7.2.4 PELVIC & ABDOMINAL MRI
7.2.5 BREAST MRI
7.2.6 CARDIAC MRI
7.3 ULTRASOUND SYSTEMS
7.3.1 RADIOLOGY/GENERAL IMAGING
7.3.2 OBSTETRICS/GYNECOLOGY
7.3.3 CARDIOLOGY
7.3.4 VASCULAR APPLICATIONS
7.3.5 UROLOGY
7.3.6 OTHER APPLICATIONS
7.4 CT SCANNERS
7.4.1 CARDIOLOGY
7.4.2 ONCOLOGY
7.4.3 NEUROLOGY
7.4.4 OTHER APPLICATIONS
7.5 NUCLEAR IMAGING SYSTEMS
7.5.1 CARDIOLOGY
7.5.2 ONCOLOGY
7.5.3 NEUROLOGY
7.5.4 OTHER APPLICATIONS UROLOGY
7.6 NUCLEAR IMAGING SYSTEMS
7.6.1 CARDIOLOGY
7.6.2 ONCOLOGY
7.6.3 NEUROLOGY
7.6.4 OTHER APPLICATIONS UROLOGY
7.7 MAMMOGRAPHY SYSTEMS

8 DIAGNOSTIC IMAGING MARKET, BY END-USER (USD MILLION; 2021—2028)*
8.1 HOSPITALS
8.2 DIAGNOSTIC CENTERS AND IMAGING CLINICS
8.2 AMBULATORY CARE CENTERS, AND PHYSICIAN’S CLINICS
8.4 OTHER END USERS

9 DIAGNOSTIC IMAGING MARKET, BY REGION (USD MILLION; 2021—2028)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 RECESSION IMPACT
9.2.2 US
9.2.3 CANADA
9.3 EUROPE
9.3.1 RECESSION IMPACT
9.3.2 GERMANY
9.3.3 UK
9.3.4 FRANCE
9.3.5 ITALY
9.3.6 SPAIN
9.3.7 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 RECESSION IMPACT
9.4.2 JAPAN
9.4.3 CHINA
9.4.4 INDIA
9.4.5 SOUTH KOREA
9.4.6 AUSTRALIA
9.4.7 REST OF ASIA-PACIFIC
9.5 LATIN AMERICA
9.5.1 RECESSION IMPACT
9.5.2 BRAZIL
9.5.3 MEXICO
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 RECESSION IMPACT

10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN (2021-2023)
10.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
10.4 MARKET SHARE ANALYSIS BY KEY PLAYERS 2022
10.4.1 GLOBAL DIAGNOSTIC IMAGING MARKET
10.4.1 GLOBAL X-RAY IMAGING SYSTEMS MARKET
10.4.1 GLOBAL MRI SYSTEMS MARKET
10.4.1 GLOBAL CT SCANNERS MARKET
10.4.1 GLOBAL NUCLEAR IMAGING SYSTEMS MARKET
10.4.1 GLOBAL MAMMOGRAPHY SYSTEMS MARKET
10.4.1 ULTRASOUND SYSTEMS MARKET
10.5 COMPANY EVALUATION MATRIX
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.6 START-UP/SME EVALUATION MATRIX
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.7 C0OMPETITIVE SITUATION AND TRENDS (2021-2023)
10.7.1 NEW PRODUCT LAUNCHES & APPROVALS
10.7.2 DEALS
10.7.3 OTHER DEVELOPMENTS
10.8 COMPETITIVE BENCHMARKING

11 COMPANY PROFILES**
(Business Overview, Products Offered, Industry-specific Developments for 2021-2023)***
11.1 SIEMENS HELATHINEERS
11.2 GE HEALTHCARE
11.3 KONINKLIJKE PHILIPS N.V.
11.4 CANON INC.FUJIFILM HOLDINGS CORPORATION
11.5 HITACHI LTD.
11.6 SAMSUNG ELECTRONIC CO., LTD.
11.7 SHIMADZU CORPORATION
11.8 AFGA-GEVAERT
11.9 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
11.10 ESAOTE SPA
11.11 HOLOGIC INC.
11.12 PLANMED OY
11.13 CURVE BEAM
11.14 KONICA MINOLTA
11.15 STERNMED
11.16 ALLENGERS
11.17 NP JSC AMICO.
11.18 NEUSOFT MEDICAL SYSTEMS
11.19 ANALOGIC CORPORATION
11.20 TRIVITRON HEALTHCARE
11.21 CURA HEALTHCARE
11.22 BRUKER CORPORATION.
11.23 AURORA HEALTHCARE US CORP
11.24 ASPECT IMAGING.
11.25 MICRIMA LIMITED

12 APPENDIX